Picture of Viveve Medical logo

VIVE — Viveve Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Viveve Medical Announces FDA Approval To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence

July 7 (Reuters) - Viveve Medical Inc  VIVE.O :
    * VIVEVE MEDICAL INC ANNOUNCES FDA APPROVAL TO CONDUCT
PURSUIT
TRIAL FOR IMPROVEMENT OF STRESS URINARY INCONTINENCE
    * VIVEVE MEDICAL INC - INITIATION OF PIVOTAL PURSUIT TRIAL
IS
TARGETED FOR Q4 2020 FOLLOWING PENDING RESULTS FROM COMPANY'S
SUI FEASIBILITY STUDY

Source: (https://bit.ly/2ACb9n7)
Further company coverage:  VIVE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Viveve Medical

See all news